Clinical trial
Feasibility of Utilizing the Infinitome Program to Evaluate Abnormal Large Scale Brain Networks in Alzheimer's Disease
NCT04563767 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of Utilizing the Infinitome Program to Evaluate Abnormal Large Scale Brain Networks in Alzheimer's Disease
- Lead sponsor
- HealthPartners Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 15, 2020
- Completion date
- October 13, 2020
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.